Endralazine

Endralazine

Clinical data
ATC code	C02DB03 (WHO)
Pharmacokinetic data
Bioavailability	C14H15N5O
Identifiers
PubChem CID	47608
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Molar mass	269.3018

WikiDoc Resources for Endralazine
Articles
Most recent articles on Endralazine Most cited articles on Endralazine Review articles on Endralazine Articles on Endralazine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Endralazine Images of Endralazine Photos of Endralazine Podcasts & MP3s on Endralazine Videos on Endralazine
Evidence Based Medicine
Cochrane Collaboration on Endralazine Bandolier on Endralazine TRIP on Endralazine
Clinical Trials
Ongoing Trials on Endralazine at Clinical Trials.gov Trial results on Endralazine Clinical Trials on Endralazine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Endralazine NICE Guidance on Endralazine NHS PRODIGY Guidance FDA on Endralazine CDC on Endralazine
Books
Books on Endralazine
News
Endralazine in the news Be alerted to news on Endralazine News trends on Endralazine
Commentary
Blogs on Endralazine
Definitions
Definitions of Endralazine
Patient Resources / Community
Patient resources on Endralazine Discussion groups on Endralazine Patient Handouts on Endralazine Directions to Hospitals Treating Endralazine Risk calculators and risk factors for Endralazine
Healthcare Provider Resources
Symptoms of Endralazine Causes & Risk Factors for Endralazine Diagnostic studies for Endralazine Treatment of Endralazine
Continuing Medical Education (CME)
CME Programs on Endralazine
International
Endralazine en Espanol Endralazine en Francais
Business
Endralazine in the Marketplace Patents on Endralazine
Experimental / Informatics
List of terms related to Endralazine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Endralazine is an antihypertensive of the hydrazinophthalazine chemical class.